Our news

By Martin Holm-Petersen, CEO Insife As we approach the end of 2023, I wanted to send my sincere thanks to everyone we have worked with...

In a sincere effort to enhance our global presence and promote a collaborative atmosphere, our CEO, Martin Holm-Petersen, and the Head of...

We're delighted to share that Insife was a gold sponsor at the Nordic Pharmacovigilance Day on November 16 in Copenhagen. The event...

We were at the World Drug Safety Congress Americas in Boston and we couldn't have asked for a better platform to showcase our innovative...

We attended the 2023 World Drug Safety Congress Europe in Amsterdam, an esteemed event that brought together professionals and experts...

At Insife, we take immense pride in our dedicated team of professionals who continually drive innovation and excellence in the field of...

At Insife, we're not merely involved in pharmacovigilance; we're pioneers of innovation in drug safety. Our recently concluded annual...

In an exhilarating triumph, we proudly secured the prestigious title of "Pharma Supplier of the Year" at the esteemed Pharma Industry...

GRIP is a unique and extremely cost effective way to deal with global regulatory intelligence in the pharmacovigilance (PV) space across...

Hurray! We turned 6 years old this year. It feels like just yesterday when we started as a tiny company in a shared office in Copenhagen,...

Copenhagen recently hosted the highly anticipated DHL Relay, an energetic event that attracted participants from all around. Each year,...

We are delighted to announce that Insife has been nominated for the prestigious title of "Pharma Supplier of the Year" by the Pharma...